370 related articles for article (PubMed ID: 30645026)
41. Platelet retention in inflamed glomeruli occurs via selective prolongation of interactions with immune cells.
Finsterbusch M; Norman MU; Hall P; Kitching AR; Hickey MJ
Kidney Int; 2019 Feb; 95(2):363-374. PubMed ID: 30522769
[TBL] [Abstract][Full Text] [Related]
42. Megakaryocytes in the lung: History and future perspectives.
Livada AC; Pariser DN; Morrell CN
Res Pract Thromb Haemost; 2023 Feb; 7(2):100053. PubMed ID: 37063766
[TBL] [Abstract][Full Text] [Related]
43. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
44. Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform.
Dejima H; Nakanishi H; Kuroda H; Yoshimura M; Sakakura N; Ueda N; Ohta Y; Tanaka R; Mori S; Yoshida T; Hida T; Sawabata N; Yatabe Y; Sakao Y
Lung Cancer; 2018 Nov; 125():128-135. PubMed ID: 30429010
[TBL] [Abstract][Full Text] [Related]
45. Emperipolesis of neutrophils by dysmorphic megakaryocytes.
Parmley RT; Kim TH; Austin RL; Alvarado CS; Ragab AH
Am J Hematol; 1982 Dec; 13(4):303-11. PubMed ID: 7158625
[TBL] [Abstract][Full Text] [Related]
46. Simultaneous measurements of megakaryocyte-associated IgG (MAIgG) and platelet-associated IgG (PAIgG) in chronic idiopathic thrombocytopenic purpura.
Nagasawa T; Hasegawa Y; Komeno T; Itoh T; Ninomiya H; Abe T
Eur J Haematol; 1995 May; 54(5):314-20. PubMed ID: 7781756
[TBL] [Abstract][Full Text] [Related]
47. Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage.
Xu XR; Gallant RC; Ni H
Thromb Res; 2016 May; 141 Suppl 2():S76-9. PubMed ID: 27207432
[TBL] [Abstract][Full Text] [Related]
48. The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody.
Piovella F; Nalli G; Malamani GD; Majolino I; Frassoni F; Sitar GM; Ruggeri A; Dell'Orbo C; Ascari E
Br J Haematol; 1978 Jun; 39(2):209-13. PubMed ID: 678473
[TBL] [Abstract][Full Text] [Related]
49. Proliferation, migration and platelet release by megakaryocytes in long-term bone marrow culture in collagen gel.
Mori M; Tsuchiyama J; Okada S
Cell Struct Funct; 1993 Dec; 18(6):409-17. PubMed ID: 8033222
[TBL] [Abstract][Full Text] [Related]
50. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases.
Maugeri N; Baldini M; Ramirez GA; Rovere-Querini P; Manfredi AA
Thromb Res; 2012 Mar; 129(3):267-73. PubMed ID: 22245222
[TBL] [Abstract][Full Text] [Related]
51. Cell biology. Beyond clotting: the powers of platelets.
Leslie M
Science; 2010 Apr; 328(5978):562-4. PubMed ID: 20430990
[No Abstract] [Full Text] [Related]
52. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.
Stahl CP; Zucker-Franklin D; McDonald TP
Blood; 1986 Feb; 67(2):421-8. PubMed ID: 3510680
[TBL] [Abstract][Full Text] [Related]
53. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
54. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
[TBL] [Abstract][Full Text] [Related]
55. Impact of Itga2-Gp6-double collagen receptor deficient mice for bone marrow megakaryocytes and platelets.
Semeniak D; Faber K; Öftering P; Manukjan G; Schulze H
PLoS One; 2019; 14(8):e0216839. PubMed ID: 31398205
[TBL] [Abstract][Full Text] [Related]
56. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets.
Kowalska MA; Ratajczak J; Hoxie J; Brass LF; Gewirtz A; Poncz M; Ratajczak MZ
Br J Haematol; 1999 Feb; 104(2):220-9. PubMed ID: 10050701
[TBL] [Abstract][Full Text] [Related]
57. Platelet Toll-like receptor expression: the link between "danger" ligands and inflammation.
Garraud O; Cognasse F
Inflamm Allergy Drug Targets; 2010 Dec; 9(5):322-33. PubMed ID: 20518724
[TBL] [Abstract][Full Text] [Related]
58. Reduced miR-26b Expression in Megakaryocytes and Platelets Contributes to Elevated Level of Platelet Activation Status in Sepsis.
Szilágyi B; Fejes Z; Póliska S; Pócsi M; Czimmerer Z; Patsalos A; Fenyvesi F; Rusznyák Á; Nagy G; Kerekes G; Berhés M; Szűcs I; Kunapuli SP; Kappelmayer J; Nagy B
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013235
[TBL] [Abstract][Full Text] [Related]
59. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura.
McMillan R; Luiken GA; Levy R; Yelenosky R; Longmire RL
JAMA; 1978 Jun; 239(23):2460-2. PubMed ID: 565830
[TBL] [Abstract][Full Text] [Related]
60. In vitro platelet release by rat megakaryocytes: effect of heterologous antiplatelet serum.
Handagama PJ; Jain NC; Feldman BF; Farver TB; Kono CS
Am J Vet Res; 1987 Jul; 48(7):1147-9. PubMed ID: 3631702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
